ARCT Operating Cash Flow Growth
Arcturus Therapeutics Holdings Inc · Operating Cash Flow Growth
ARCT Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.99%period ending
ARCT TTM Cash from Operations YoY % (-1072.86% → -11.99%)
Year-over-year change
High-resolution chart · PNG
ARCT operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -11.9924% | |
| 34.4282% | |
| -24.3092% | |
| 2.9355% | |
| 5.5184% | |
| -831.2976% | |
| -230.1122% | |
| -142.0845% | |
| -151.7618% | |
| -72.9523% | |
| -156.5718% | |
| 183.6182% | |
| 191.5723% | |
| 131.9991% | |
| 123.691% | |
| -72.1783% | |
| -47.3649% | |
| -90.8401% | |
| -215.072% | |
| -126.6045% | |
| -220.2565% | |
| -473.6348% | |
| -565.0272% | |
| -837.1949% | |
| -256.0783% | |
| 50.0504% | |
| 68.9547% | |
| 8.8425% | |
| -2,652.9586% | |
| -722.9785% | |
| -4,413.0435% | |
| 64.3171% | |
| 101.7159% | |
| 120.9581% | |
| 97.6093% | |
| 26.363% | |
| -8.201% | |
| -9.8833% | |
| -6.0227% | |
| 9.7779% | |
| 29.213% | |
| 34.0905% | |
| 35.9362% | |
| 14.8106% | |
| -43.9333% | |
| -114.0952% | |
| -287.9485% | |
| -808.8857% | |
| -1,482.6395% | |
| -1,072.8611% |